Literature DB >> 19092111

Will tricyclic antidepressants make a comeback for depressed Parkinson disease patients?

Michael S Okun, Hubert H Fernandez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19092111     DOI: 10.1212/01.wnl.0000338145.24512.02

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

1.  A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

Authors:  I H Richard; M P McDermott; R Kurlan; J M Lyness; P G Como; N Pearson; S A Factor; J Juncos; C Serrano Ramos; M Brodsky; C Manning; L Marsh; L Shulman; H H Fernandez; K J Black; M Panisset; C W Christine; W Jiang; C Singer; S Horn; R Pfeiffer; D Rottenberg; J Slevin; L Elmer; D Press; H C Hyson; W McDonald
Journal:  Neurology       Date:  2012-04-11       Impact factor: 9.910

Review 2.  Parkinson disease: an update.

Authors:  Steven J Frucht
Journal:  Neurologist       Date:  2004-07       Impact factor: 1.398

3.  The role of cognitive-behavioural therapy for patients with depression in Parkinson's disease.

Authors:  Andreas Charidimou; John Seamons; Caroline Selai; Anette Schrag
Journal:  Parkinsons Dis       Date:  2011-06-08

4.  Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis.

Authors:  Jinling Liu; Jiangchuan Dong; Lei Wang; Ying Su; Peng Yan; Shenggang Sun
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.